I was sensitive about sharing my journey because I didnt want anyone to know what I was up to until I felt like this shift was really real
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
All skeletal cells express IGF-I and IGF-IR
However, the introduction of semaglutide tablets and the development of higher-dose oral Read More GLP1s and Liver Disease: Rethinking MASLD Care Beyond Obesity and A1C Jan 26, 2026 Articles, Diabetes, Featured, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 2,667 views Nonalcoholic steatohepatitis (NASH) and metabolic dysfunctionassociated steatotic liver disease (MASLD) are rapidly becoming leading causes of chronic liver disease worldwide
This could protect against various infections and diseases, contributing to a stronger, more resilient immune system
GLP-1 therapies have become a key part of todays diabetes treatment algorithm, helping providers balance glucose control, cardiovascular risk, and patient preferences